Silo Pharma Inc. logo

Silo Pharma Inc.

SILO | NASDAQ
Chart Builder DCF Calculator
$1.23
-$0.02 (-1.60%)
At close: Oct 30, 2026, 4:00 PM ET
$1.23
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
4.75M 3.91M 3.52M 11.37M 9.84M 1.13M
Short-Term Investments
2.11M 3.17M 4.14M 3.12K 420K 200
Long-Term Investments
n/a n/a n/a n/a 61.21K n/a
Other Long-Term Assets
n/a 59.15K 64.98K 70.82K 26.66K n/a
Receivables
n/a n/a n/a 66.01K n/a 23.5K
Inventory
n/a n/a n/a n/a n/a 33.48K
Other Current Assets
528.96K 30.96K 15.97K n/a 145.32K n/a
Total Current Assets
7.39M 7.11M 7.68M 11.57M 10.4M 1.43M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
217.38K 241.22K n/a n/a n/a n/a
Total Long-Term Assets
217.38K 300.36K 64.98K 70.82K 87.87K n/a
Total Assets
7.61M 7.41M 7.75M 11.64M 10.49M 1.43M
Account Payables
578.08K 1.58M 703.49K 364.22K 417.94K 127.07K
Deferred Revenue
72.1K 72.1K 72.1K 72.1K 72.1K n/a
Short-Term Debt
n/a n/a n/a n/a n/a 14.65K
Other Current Liabilities
n/a n/a n/a n/a n/a n/a
Total Current Liabilities
650.18K 1.66M 775.59K 436.32K 490.04K 141.72K
Long-Term Debt
n/a n/a n/a n/a n/a 4.25K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
649.48K 721.58K 793.68K 865.78K 937.88K 4.25K
Total Liabilities
1.3M 2.38M 1.57M 1.3M 1.43M 145.97K
Total Debt
n/a n/a n/a n/a n/a 18.9K
Book Value
6.31M 5.03M 6.18M 10.34M 9.06M 1.28M
Book Value Per Share
11.28 20.52 30.08 67.91 70.86 14.56
Common Stock
1.33K 449 316 316 9.86K 8.51K
Retained Earnings
-19.49M -15.26M -10.87M -7.17M -3.26M -5.76M
Comprehensive Income
5.83K 2.42K -6.23K n/a n/a n/a
Shareholders Equity
6.31M 5.03M 6.18M 10.34M 9.06M 1.28M
Total Investments
2.11M 3.17M 4.14M 3.12K 481.21K 200

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.